Rensselaer Researcher Receives $2.1 Million Grant To Develop Treatment for Anthrax
Troy, N.Y. — Rensselaer Polytechnic Institute researcher Ravi Kane has been awarded $2.1 million in National Institutes of Health (NIH) funding to develop an antidote to counteract the potentially deadly anthrax toxin in humans who have been exposed to the bacteria's spores.